Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 3Gastrointestinal 3Genitourinary 2Thoracic 1Classical hematology 1

Conditions

Mouth Neoplasms 1Fanconi Anemia 1

Interventions

Cyclophosphamide 24fludarabine phosphate 18Whole-Body Irradiation 17fludarabine 16Mycophenolic Acid 16Tacrolimus 12Peripheral Blood Stem Cell Transplantation 12Busulfan 12Melphalan 11apixaban 10Biopsy 7Rivaroxaban 6Granulocyte Colony-Stimulating Factor 6Specimen Handling 5Filgrastim 5Cyclosporine 5Azacitidine 5thymoglobulin 4X-Rays 4Sirolimus 4Rituximab 4Injections 4Enoxaparin 4Decitabine 4Bone Marrow Transplantation 4Aspirin 4Antilymphocyte Serum 4venetoclax 3pegylated granulocyte colony-stimulating factor 3hetrombopag 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Ethanol × Classical hematology × 1 year × Clear all
NCT05973656 2025-08-22

Role of Acetaldehyde in the Development of Oral Cancer

Masonic Cancer Center, University of Minnesota

Phase NA Recruiting
170 enrolled
Classical hematologyHead & Neck

Fanconi Anemia, Mouth Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡